Utilizing real world evidence (RWE) of disease burden and performance of technologies in clinical practice settings is increasingly a focus of the healthcare industry. However, the willingness and ability to use RWE in reimbursement decision-making varies significantly. This research aims to classify major national payers into archetypes based on their use of RWE in decision-making.
Authors: Macaulay R, Tang M, PAREXEL International, London, United Kingdom
To find out more about this poster you can register to download it here after the ISPOR event.